Company BioInvent International AB (publ) Nasdaq Stockholm
Equities
BINV BTA
SE0014684486
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- SEK | -.--% | -4.18% | -.--% |
Business Summary
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 326 | 100.0 % | 71 | 100.0 % | -78.09% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
66.3
%
| 273 | 83.8 % | 47 | 66.3 % | -82.66% |
Sweden
25.6
%
| 26 | 7.9 % | 18 | 25.6 % | -28.75% |
Europe
4.1
%
| 27 | 8.3 % | 3 | 4.1 % | -89.11% |
Other Countries
4.0
%
| - | - | 3 | 4.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Martin Welschof
CEO | Chief Executive Officer | 63 | 31/08/18 |
Stefan Ericsson
DFI | Director of Finance/CFO | 61 | 31/12/97 |
Marie Moores
COO | Chief Operating Officer | - | 31/01/22 |
Björn Frendéus
CTO | Chief Tech/Sci/R&D Officer | 51 | 31/12/00 |
Chief Tech/Sci/R&D Officer | 68 | 31/12/16 | |
Investor Relations Contact | - | 31/01/21 | |
Emma Meurling
HRO | Human Resources Officer | - | - |
General Counsel | - | 11/06/23 | |
Corporate Officer/Principal | - | 08/06/22 | |
Corporate Officer/Principal | 50 | 31/12/15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bernd Seizinger
BRD | Director/Board Member | 67 | 31/12/17 |
Leonard Kruimer
CHM | Chairman | 66 | 11/05/16 |
Vincent Ossipow
BRD | Director/Board Member | 55 | 11/05/16 |
Thomas O. Hecht
BRD | Director/Board Member | 73 | 02/07/20 |
Erik Esveld
BRD | Director/Board Member | - | 28/04/21 |
Director/Board Member | 49 | 11/07/22 | |
Director/Board Member | 56 | 31/12/17 | |
Natalie Berner
BRD | Director/Board Member | 34 | 11/07/22 |
Martin Pålsson
BRD | Director/Board Member | 45 | 31/12/21 |
Elin Birgersson
BRD | Director/Board Member | 39 | 31/12/22 |
Company contact information
BioInvent International AB
The Gamma Building Ideongatan 1
223 70, Lund
+46 4 62 86 85 50
http://www.bioinvent.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- BINV Stock
- BINV BTA Stock
- Company BioInvent International AB (publ)